In this week’s issue:
Sent on Feb. 1st, 2012:
As you may have seen, the Michael Smith Foundation for Health Research today launched a new funding competition for the Career Investigator Program – Scholar Award. Please note that we are not launching a Trainee Award competition (for graduate students and post-doctoral researchers) at this time.
On behalf of our staff, I wanted to advise you personally of this very positive news and take the opportunity to thank you for your ongoing support of MSFHR. We look forward to working with you further to build BC’s health research enterprise to its full potential.
Bruce Clayman, PhD
Interim President and CEO
Michael Smith Foundation for Health Research
· Michael Smith Foundation for Health Research – Career Investigator Program – Scholar Award
· Epilepsy Therapy Project/Epilepsy Foundation – Spring 2012 New Therapy – Commercialization Grants
· Simons Foundation Autism Research Initiative – Mouse Phenotyping RFA
· Canadian Institutes of Health Research (CIHR) – Innovation Team Grants: Community-Based Primary Healthcare (CBPHC)
· Branch for International Surgery – Global Surgery Research Awards
LOI Deadline: February 24, 2012
Internal FoM Deadline: TBA
Full Application Deadline: March 23, 2012
The Michael Smith Foundation for Health Research is excited to announce the launch of a new funding competition for the Career Investigator Program – Scholar Award.
These awards represent one of the cornerstones of our investment in nurturing talent and building research capacity in British Columbia. Since 2001, our personnel programs have supported more than 1,450 individual researchers working across all areas of health research. MSFHR funding helps foster the development of outstanding health researchers by providing a vital source of support that allows them to build strong research programs, engage collaborators and teams, and attract additional funding to advance knowledge on critical health issues. Past recipients of this award have achieved numerous discoveries and “world firsts” that have improved health and saved lives in BC and around the world.
More information about this funding opportunity, including guidelines and instructions, may be found on the Career Investigator Program page, linked to above.
Internal Faculty of Medicine procedures and timelines will be distributed once available.
LOI deadline: March 1, 2012
The mission of the New Therapy – Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development.
A total of $500,000 is available for funding for the Spring 2012 grant cycle. Although we anticipate awarding grants of $100,000 on average, we strongly encourage proposals ranging from $50,000 – $500,000. Multi-year proposals are also welcome, and will be considered.
Deadline: March 5, 2012
To maximize the ability to make direct comparisons among mouse models, this Request for Applications seeks applications for systematic, rigorous and scalable analyses of behavioral phenotypes across multiple mouse models. The data produced in this effort will be made available to the research community with minimum delay and thus will be a valuable resource for all researchers.
There is no budget cap. Proposals should include a realistic budget sufficiently detailed for evaluation of needed resources. SFARI will work closely with investigators with competitive applications to arrive at a suitable budget.
LOI Deadline: May 1st, 2012
Full Application Deadline: October 15th, 2012
CIHR and its partners are pleased to announce the launch of the Innovation Team Grants: Community-Based Primary Healthcare (CBPHC) funding opportunity CIHR and its partners will provide funding for teams undertaking programmatic, cross-jurisdictional and interdisciplinary research to develop, implement, evaluate, and compare innovative models for chronic disease prevention and management in CBPHC and improving access to appropriate CBPHC for vulnerable populations.
Up to $ 31,665,000 over five years is available through this funding opportunity to support Canada-based teams (additional funds through partners in Australia and New Zealand will available to components of the teams based in those countries).
CIHR is hosting an information webinar for interested applicants to learn more about the launch of the Innovation Team Grants: Community-Based Primary Healthcare (CBPHC) funding opportunity (e.g., objectives, eligibility, review process, etc.). We invite you to RSVP for the webinar, which will be held on February 9 at 2.30pm EST.
Deadline: May 27, 2012
The Branch Global Surgery Research Awards provide financial assistance to a surgical resident (General Surgery, Orthopedics, Ophthalmology, Anesthesia, Urology, Obstetrics & Gynecology) at the University of British Columbia so that they may gain valuable international fieldwork experience in the burden of unmet surgical care in developing countries. The funds have been generously provided through the Branch’s alliance with the Canadian Network of International Surgery (CNIS) through a CIDA grant.
Up to four grants of $2500 will be provided and can be used to support travel costs. Funds can be used for research projects taking place anytime from summer quarter 2012 up to, and including spring quarter 2013.
Applicants will be selected based on the following considerations:
- the strength and quality of the project proposal
- evidence of the educational value for Resident and host country
- focus on surgical care in a resource limited setting
- research results have potential to be disseminated –publications and conferences
- evidence of field planning and approval from host country and recommendation of the UBC Program Director